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Although numerous histopathological and immunohistochemical approaches have been reported on spontaneously and estrogen-induced rat pituitary tumors (1, 2, 7, 12, 13) , pituitary carcinoma with pars intermedia cell differentiation of the pars distalis has not been described.
Alpha-melanocyte-stimulating hormone (a-MSH), a peptide hormone, derives from pro-opiomelanocortin (POMC) processing in the pars intermedia cells and is thought to be a marker of the pars intermedia cells (3, 10) . Tumor cells containing a.-MSH of the pars distalis have been previously described in humans and dogs with Cushing's disease (3, 6, 8, 9, 11) . In the rat pituitary tumor, however, cells containing a-MSH have not been verified so far.
In our 2-year carcinogenicity study using F344 rats, 2 (1 male and 1 female) rats showed spontaneous invasive pituitary tumors with different histological patterns from the others. To clarify the histological features of these tumor cells, the tumors were examined by the histopathological and hormone immunohistochemical procedures including the a-MSH staining.
F344/Ducrj rats (Charles River Japan Inc, Kanagawa, Japan) from control and treated groups utilized in a 2year carcinogenicity study (167 males and 169 females) were chosen for investigation. Among these rats, 39 rats (14 males and 25 females) possessed invasive pituitary tumors in the pars distalis. Out of the 39 animals, 1 male and 1 female, showing invasive tumors with a different histological pattern from the rest at an age of 110 weeks, were subjected to the present study.
At necropsy, the pituitary was carefully removed to-gether with surrounding tissues including the capsule, venous vessels, peripheral nerves, and the sphenoid bone.
These tissues were fixed in 10% neutral buffered formalin and then decalcified in buffered 25 % formic acid. The pituitary and the surrounding tissues were trimmed sagittally (male) or transversely (female) in order to facilitate detection of tumor cell invasion of the surrounding tissues (13, 14) . Afterward, the specimens were embedded in paraffin wax, cut, and stained with hematoxylin and eosin (H&E) or aldehyde/thionin/periodic acid-Schiff/orange G. Other major organs and tissues were also stained with H&E via the standard methods for light microscopic examination.
For immunohistochemical detection of a-MSH, prolactin (PRL), and proliferating cell nuclear antigen (PCNA), selected tissue sections were processed by a labeled streptavidin-biotin (LSAB) method. In brief, the paraffin section was deparaffinized, treated sequentially with rabbit anti-a-MSH antibody (1:500, Biogenesis, Inc, NH), rabbit anti-rat prolactin antibody (1:1,000, Chemicon International Co, Ltd, CA), or mouse anti-PCNA antibody (1:100, DAKO Japan Co., Ltd., Tokyo, Japan) as the primary antibody, followed by staining with an LSAB kit (DAKO Japan Co, Ltd). The sections were then counterstained with hematoxylin. Negative controls were performed by substituting normal goat serum for the primary antibody. Pituitaries of 110-week-old rats without tumors served as native controls. Anti-a-MSH antibody used in this investigation had no cross-reactivity with cells containing adrenocorticotropic hormone (ACTH), or POMC-derived peptides of the pars distalis cells. No staining or enhancement was demonstrable in the pars distalis cells. Specific staining was detected only in pars intermedia cells of the native control tissue. In PCNA immunohistochemistry, the section was scanned with a microscopic color image processor (SHR-6500, Keyence Co, Tokyo), and the number of positive nuclei per 100 pituitary pars distalis cells represented a proliferating cell index (%).
Formalin-fixed and embedded paraffin wax tumor tissue was processed for electron microscopy. Deparaffinized sections were postfixed with 1 % aqueous osmium tetroxide and embedded in epoxy resin. Then, ultrathin sections were stained with uranyl acetate and lead citrate, Invasion site: sphenoid bone marrow. b Composed of both positive and negative areas. Immunohistochemical scores are as follows: -= negative; + = weak positive; + + = moderately positive. and the selected target area (sphenoid bone invasion site) was examined by transmission electron microscopy.
In both animals the enlarged pituitary showed dark reddish color and compressed the surrounding tissues, especially the overlaying base of the brain. Histopathologically, the primary tumor mass consisted of blood-filled spaces and atypical round to oval neoplastic cells ( Figure   la ). Mitotic figures were observed in the invasive tumor containing irregular-sized nuclei and pleomorphic cytoplasm. Tumor cells invaded the capsule and the sphenoid bone cavity (Figure lb) . A compressed native pars intermedia was detected in the primary tumor mass. On the basis of these findings, the tumors were diagnosed as invasive carcinoma originating from the pars distalis. No distal metastases were evident in these cases. In the bone marrow cavity, the localization of neoplastic cell invasion with pars intermedia cell differentiation was noted (Figure la, b ). The tumor cells at the invasion site, arranged in lobular and nest patterns, were different from cells in the pituitary tumor mass. Furthermore, they had chromophobic to pale basophilic cytoplasm with well-defined lobular borders, somewhat similar to those in pars intermedia cells. Female tumor cells showed a more similar cell pattern than those in males by light microscopy. Tumor cells of the noninvasive primary mass were stained with PRL but not with a-MSH. On the other hand, cells invading the bone marrow exhibited a positive immunoreactivity for both PRL and a-MSH (Figure lc,  d) . These were closely correlated with the site of neoplastic invasion. The tumor cells in the male were more intensely stained with a-MSH compared with the female (Figure ld ). Remaining pars intermedia cells in the primary tumor mass were stained with a-MSH but not with PRL.
The invading cells that replaced the sphenoid bone marrow cavity displayed elevated PCNA labeling indices as compared with those of the primary tumor mass (Table   1 ).
Tumor cells invading the bone marrow cavity were characterized by abundant dilated rough endoplasmic reticulum (RER), Golgi saccules, and intracytoplasmic secretory granules of various sizes (Figure 2a, b) . The diameter of secretory granules was in a range of about 100-400 nm. Some secretory granules were smaller than that seen in PRL-secreting cells (Figure 2b ). Pituitary carcinomas arising from the pars distalis showed pars intermedia differentiation. Although the presence of a-MSH-positive cells in the pars distalis has been observed in the native pituitary of fetal rats, there are no reports on neoplastic cells in the pars distalis (4, 5) . a-MSH-related peptides are major products of POMC processing in the pars intermedia, whereas their immediate precursors, ACTH and other POMC-derived peptides, predominate in this part of the pituitary.
In the present study, the pars intermedia cell differentiation was detected only in the invasion site of the sphenoid bone marrow. The cells were positively stained with anti-a-MSH antibody. Ultrastructurally, these cells contained well-developed RER, Golgi saccules, and small secretory granules that were not seen in the PRL-secreting cells; hence, somewhat similar to these in pituitary adenoma cells of the pars intermedia (3, 10) . A further important finding is that native pars intermedia was seen in the pituitary mass. No neoplastic changes in the adrenals were noted in either rat under the present experimental conditions. Therefore, the tumor cells were distinct from ACTH-secreting cells. Based on these findings the cells were functionally and morphologically diagnosed as invasive pituitary tumors with pars intermedia cell differentiation arising from the pars distalis.
A high PCNA labeling index was detected for the cells invading the sphenoid bone marrow. In the development of pituitary tumors, because the local blood flow is reduced by compression of the sinus and overlying veins, ischemia may occur in the primary tumor mass (14) . Consequently, ischemia was considered to suppress the proliferation of carcinoma cells in the mass itself. Therefore, the high PCNA labeling index of invading tumor cells might be related to the rich blood flow in the sphenoid bone marrow.
Ontogenesis of the a-MSH cells, the first cells revealed with the anti-a-MSH antibody are observed at 16-18 days of fetal age in the pars distalis near the sphenoid bone. They are very numerous in late gestation (4, 5) . Meanwhile, PRL cells are observed in the posterior part of the pars distalis after 21 days of fetal age (5) . PRL cells are the last cell type to appear in the fetal rat pituitary gland. Cytodifferentiation factors of the a.-MSH or PRL cells from the stem cell are not clear in detail yet. In the present cases, cause of the pars intermedia cell differentiation from the pars distalis tumor cell was also unknown. On the basis of the apparent localization of differentiated cells, we speculate that colony-stimulating factors in the bone marrow tissue contributed to pars intermedia cell differentiation.
In this paper, histopathological and immunohistochemical features of cx-MSH-containing rat pituitary tumors are described. This is the first report, to our knowledge, that describes pars intermedia differentiation with an a-MSH-positive tumor arising from the pars distalis in F344 rats.
